Asia Pacific Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, Cataplexia And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Asia Pacific Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, Cataplexia And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 6896 | Pages: 145 | April 2018 | Region: Asia Pacific


The Asia Pacific Narcolepsy Drugs Market was worth USD XX million in 2018 and estimated to be growing at a CAGR of XX%, to reach USD XX million by 2023. Narcolepsy is a neurological disorder that decreases the ability to regulate sleep cycles.

It is a long term neurological disorder that includes periods of excessive daytime sleepiness that last from seconds to minutes and can occur at any time. Sometimes these sessions can cause sudden loss of muscle loss that is termed as cataplexy, and occurs in 70% of the cases. Currently there is no cure but lifestyle changes and medications help in developing tolerance to the disorder.

Factors accountable for the growth of market are increasing number of individuals affected by this conditions and increasing severity of the diseases, favourable reimbursement policies and increasing awareness regarding the medications available to treat the disorder. On the other hand, expensive manufacturing costs and strict regulations are the factors hindering the market.

The Asia Pacific market for Narcolepsy Drugs is segmented based on Type and Indication. Based on Type it is divided into Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others. Based on Indications it is divided into Daytime Extreme Sleepiness, Cataplexia and Others. Based on geographical analysis, the market is divided into regions of China, India, Japan, South Korea and Australia. China holds the major share in the market due to presence of market leaders as well as the presence of a stellar healthcare system. India is the fastest growing region due to increasing disposable income, growing awareness and increasing adoption rate.

Some of the key players dominating this market include Ligand Pharmaceuticals, Addrenex Pharmaceuticals, Shire Plc, Teva Pharmaceutical Industries Ltd., Arena Pharmaceuticals, Jazz Pharmaceuticals Plc, Bioprojet, and Graymark Healthcare, Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Central Nervous System Stimulants             

                                5.1.3 Tricyclic Antidepressants   

                                5.1.4 Sodium Oxybate   

                                5.1.5 Selective Serotonin Reuptake Inhibitor      

                                5.1.6 Others      

                                5.1.7  Y-o-Y Growth Analysis, By Type    

                                5.1.8  Market Attractiveness Analysis, By Type  

                                5.1.9  Market Share Analysis, By Type    

                5.2 Indication                    

                                5.2.1 Introduction           

                                5.2.2 Daytime Extreme Sleepiness          

                                5.2.3 Cataplexia               

                                5.2.4 Others      

                                5.2.5 Y-o-Y Growth Analysis, By Indication           

                                5.2.6 Market Attractiveness Analysis, By Indication         

                                5.2.7 Market Share Analysis, By Indication           

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Indication

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Indication

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Ligand Pharmaceuticals                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Addrenex Pharmaceuticals                  

                8.3 Shire Plc                       

                8.4 Teva Pharmaceutical Industries Ltd.                

                8.5 Arena Pharmaceuticals                          

                8.6 Jazz Pharmaceuticals Plc                       

                8.7 Bioprojet                     

                8.8 Graymark Healthcare, Inc                     

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by indication with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Narcolepsy Drugs Market By Type, From 2018–2023 ( USD Million )
  2. Asia Pacific Central Nervous System Stimulants Market By Region, From 2018–2023 ( USD Million )
  3. Asia Pacific Tricyclic Antidepressants Market By Region, From 2018–2023 ( USD Million )
  4. Asia Pacific Sodium Oxybate Market By Region, From 2018–2023 ( USD Million )
  5. Asia Pacific Selective Serotonin Reuptake Inhibitor Market By Region, From 2018–2023 ( USD Million )
  6. Asia Pacific Others Market By Region, From 2018–2023 ( USD Million )
  7. Asia Pacific Narcolepsy Drugs Market By Indication, From 2018–2023 ( USD Million )
  8. Asia Pacific Daytime Extreme Sleepiness Market By Region, From 2018–2023 ( USD Million )
  9. Asia Pacific Cataplexia Market By Region, From 2018–2023 ( USD Million )
  10. Asia Pacific Others Market By Region, From 2018–2023 ( USD Million )
  11. Japan Narcolepsy Drugs Market By Type, From 2018–2023 ( USD Million )
  12. Japan Narcolepsy Drugs Market By Indication, From 2018–2023 ( USD Million )
  13. China Narcolepsy Drugs Market By Type, From 2018–2023 ( USD Million )
  14. China Narcolepsy Drugs Market By Indication, From 2018–2023 ( USD Million )
  15. India Narcolepsy Drugs Market By Type, From 2018–2023 ( USD Million )
  16. India Narcolepsy Drugs Market By Indication, From 2018–2023 ( USD Million )
  17. Australia Narcolepsy Drugs Market By Type, From 2018–2023 ( USD Million )
  18. Australia Narcolepsy Drugs Market By Indication, From 2018–2023 ( USD Million )
  19. South Korea Narcolepsy Drugs Market By Type, From 2018–2023 ( USD Million )
  20. South Korea Narcolepsy Drugs Market By Indication, From 2018–2023 ( USD Million )
Middle East and Africa Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables...
Latin America Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Asia-Pacific Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrume...
Europe Microbial Identification Market By Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), ...
North America Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instrum...
Microbial Identification Market by Method (Genotypic, Proteomics-based, Phenotypic), Application (F&B, Diagnostic, Pharmaceutical, Environmental), Product (Identification Services, Consumables, Instruments), End Use...
Middle East & Africa Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by...
Latin America Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techni...
Asia Pacific Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techniq...
Europe Cell Harvesting Systems Market By Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), By End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centers), By Techniques (B...
North America Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techni...
Cell Harvesting Systems Market by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centres), by Techniques (Blastome...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.